Lin, Chun-ChiChun-ChiLinChen, Te-HungTe-HungChenWu, Yu-ChungYu-ChungWuFang, Chuan-YinChuan-YinFangWang, Jaw-YuanJaw-YuanWangChen, Chou-PinChou-PinChenKAI-WEN HUANGJiang, Jeng-KaiJeng-KaiJiang2021-04-292021-04-292021-0310689265https://scholars.lib.ntu.edu.tw/handle/123456789/558340Taiwan has witnessed a surge in the incidence of colorectal cancer (CRC), of which 40-60% metastasize. Continuous updating of cytoreductive strategies in metastatic CRC (mCRC) has contributed to median overall survival reaching 40 months. In this changing scenario, to standardize the approaches across Taiwan, a group of experts from the Taiwan Society of Colon and Rectal Surgeons (TSCRS) convened to establish evidence- and opinion-based recommendations for defining the criteria of "resectability" in mCRC.en[SDGs]SDG3Article; colorectal surgeon; consensus; consultation; cytoreductive surgery; general surgeon; human; liver metastasis; medical expert; medical oncologist; medical specialist; meta analysis; metastasis resection; metastatic colorectal cancer; peritoneum mejournal article10.1245/s10434-020-08914-8328754642-s2.0-85090127771https://api.elsevier.com/content/abstract/scopus_id/85090127771